Antiallergic Activity of 3-O-Dodecyl-l-ascorbic Acid.

Area of Science:

• Medicinal Chemistry
• Immunology
• Pharmacology

Background:

• Ascorbic acid (vitamin C) derivatives are explored for therapeutic applications.
• Mast cell degranulation is a key process in allergic reactions.
• Inhibiting degranulation is a target strategy for antiallergic drug development.

Purpose of the Study:

• To synthesize novel 2-O-alkyl and 3-O-alkyl ascorbic acid derivatives.
• To evaluate the inhibitory activity of these derivatives on mast cell degranulation.
• To assess the in vivo antiallergic potential of the most active compound.

Main Methods:

• Synthesis of various alkylated ascorbic acid derivatives.
• In vitro evaluation of inhibitory activity against antigen- and calcium ionophore-stimulated degranulation.
• In vivo assessment of passive cutaneous anaphylaxis (PCA) reactions in mice following oral administration.

Main Results:

• 3-O-dodecyl-l-ascorbic acid (compound 8) exhibited the strongest inhibition of antigen-stimulated degranulation among tested derivatives.
• Compound 8 also effectively inhibited calcium ionophore-induced degranulation.
• Orally administered compound 8 showed antiallergic efficacy in a mouse PCA model, comparable to oxatomide.

Conclusions:

• 3-O-dodecyl-l-ascorbic acid is a potent inhibitor of mast cell degranulation.
• Compound 8 demonstrates significant in vivo antiallergic activity.
• This ascorbic acid derivative represents a promising candidate for future antiallergic therapies.